VNUS to market Medtronic's U-Clip:
This article was originally published in Clinica
Executive Summary
VNUS Medical Technologies, a San Jose, California-based company focused on minimally-invasive treatments of venous reflux disease, has acquired exclusive rights to distribute Medtronic's U-Clip anastomotic device in the US vascular surgery market. The U-Clip is a self-closing device made from nitinol, designed to create connections between blood vessels - or anastomoses - without the need for tying knots or managing sutures. The quality of anastomoses is critical to the long-term success of procedures such as peripheral bypass surgery and arteriovenous access surgery.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.